Home > Insider Trading > Filing (0001225208-17-012827)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
701221	Cigna Corp	CI	Hospital & Medical Service Plans (6324)	061059331

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1480601	G Matthew Manders	900 Cottage Grove Road Bloomfield CT 06002	Pres. Gov't & Ind Prog & Group	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $.25 Par Value	Acquisiton	2017-07-20	12,457	$44.43	46,256	No	4	M	Direct
Common Stock, $.25 Par Value	Disposition	2017-07-20	12,457	$175.01	33,799	No	4	S	Direct
Common Stock, $.25 Par Value	Acquisiton	2017-07-21	11,900	$44.43	45,699	No	4	M	Direct
Common Stock, $.25 Par Value	Disposition	2017-07-21	11,900	$175.01	33,799	No	4	S	Direct
Common Stock, $.25 Par Value	Acquisiton	2017-07-24	5,596	$44.43	39,395	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $.25 Par Value	Employee Stock Option (Right to Buy)	Disposition	2017-07-20	12,457	$0.00	12,457	$44.43
Common Stock, $.25 Par Value	Employee Stock Option (Right to Buy)	Disposition	2017-07-21	11,900	$0.00	11,900	$44.43
Common Stock, $.25 Par Value	Employee Stock Option (Right to Buy)	Disposition	2017-07-24	5,596	$0.00	5,596	$44.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,496	2013-02-28	2022-02-28	No	4	M	Direct
5,596	2013-02-28	2022-02-28	No	4	M	Direct
0	2013-02-28	2022-02-28	No	4	M	Direct

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
Represents the weighted average price of the shares sold. The prices actually received ranged from $175.00 to $175.01 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Represents the weighted average price of the shares sold. The prices actually received ranged from $175.00 to $175.06 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
This option was granted on February 28, 2012. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.